KB63.4ICD-11 MMS 2026-01
Transitory tyrosinaemia of newborn
Description
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age.
Coding note from above levels
Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.
Index terms
- Transitory tyrosinaemia of newborn
- neonatal tyrosinemia
- transient neonatal hypertyrosinemia
Show allHide
- transitory neonatal tyrosinemia
Exclusions from above levels
01– Certain infectious or parasitic diseases - acquired after birth02– Neoplasms05– Endocrine, nutritional or metabolic diseases
Show allHide
08– Certain congenital diseases of the nervous system20– Congenital malformations, deformations and chromosomal abnormalities22– Injury, poisoning or certain other consequences of external causes3A10– Hereditary haemolytic anaemia4A01.03– Transient hypogammaglobulinaemia of infancy9B71.3– Retinopathy of prematurityBC43– congenital cardiomyopathyDA93.0– Paralytic ileusEA50.Z– Pemphigus neonatorumEH40.00– Cradle cap- http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
- http://id.who.int/icd/entity/609214049 – Congenital gonococcal infection
Sibling codes
Foundation entity
Transitory tyrosinaemia of newborn – http://id.who.int/icd/entity/25668130
Part of: KB63: Certain specified transitory neonatal electrolyte or metabolic disturbances › 19: Certain conditions originating in the perinatal period